Skip to content
Research Article Open access CC BY 4.0

Eosinophilic Esophagitis during Milk Oral Immunotherapy in a Child with Severe IgE-Mediated CMPA: A Case Report

Sara Moujtahid, Said Ettair

Journal of Scientific Research and Reports · pp. 879–884 · Published 23 Oct 2025

10.9734/jsrr/2025/v31i103632

Abstract

Background: Oral immunotherapy (OIT) for persistent cow’s milk protein allergy (CMPA) can improve protection against accidental exposures, but gastrointestinal adverse events, including eosinophilic esophagitis (EoE), are increasingly recognized. Case: A 4.5-year-old boy with severe IgE-mediated CMPA and atopy began milk OIT.  After 6 weeks he developed odynophagia, dysphagia, vomiting, anorexia, and weight stagnation. Diagnosis & Treatment: Upper endoscopy showed EoE with peak 78 eosinophils/high-power field (eos/HPF). A strict milk-free diet, proton-pump inhibitor, and swallowed topical budesonide were initiated. Outcome: Symptoms resolved with weight catch-up; follow-up biopsies at 3 months showed remission (3 eos/HPF). Conclusion: In high-risk, highly atopic children, OIT warrants close clinical and endoscopic monitoring. When EoE is suspected, guideline-based evaluation (EREFS, ≥6 biopsies from ≥2 levels) and early anti-inflammatory therapy are recommended.

Cow’s milk protein allergy oral immunotherapy eosinophilic esophagitis child atopy

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.